期刊文献+

ICU抗菌药物耐药与临床药学监护 被引量:1

Clinical Pharmaceutical Care to Antibiotic Drug Resistance in Intensive Care Unit
下载PDF
导出
摘要 临床药师可以积极参与到重症监护室(Intensive care unit,ICU)抗菌药物临床药学监护中,尤其针对抗菌药物的耐药。临床药师可通过专业优势在药代动力学、药效动力学参数规范抗菌药物的使用并提供个体化给药方案。也可以通过监督抗菌药物轮换使用的方式减少耐药率的发生。临床药师可以与感染控制科一同监测ICU抗菌药物耐药率。并监督预防感染疫苗的使用。定期收集抗菌药物使用相关指标可以使临床药师更容易掌握耐药率情况,并通过多种渠道与临床医务人员及时沟通,有效控制ICU患者抗菌药物耐药情况。 Clinical pharmacist can play an important role to administer antibiotic use in intensive care unit, especially in the antibiotic drug resistance. Clinical pharmacist can provide personalized dosage regimen through pharmacokinetics and pharmacodynamics parameter. Clinical pharmacist can also decrease antibiotic drug resistance through monitoring the rotation of the drug. Clinical pharmacist can monitor antibiotic drug resistance rate cooperate with infection control department, and clinical pharmacist can monitor the vaccines to prevent infection. Regular collection of antibiotics using index can easily control drug resistance rate, and on time connection to clinical staffs can effectively control antibiotic drug resistance in intensive care unit.
出处 《今日药学》 CAS 2013年第1期40-42,共3页 Pharmacy Today
基金 广东省医院药学研究基金(编号:2009B020)
关键词 抗菌药物 临床药学 耐药 antibiotic drug clinical pharmacy drug resistance
  • 相关文献

参考文献6

  • 1Shlaes DM,Gerding DN,John JF Jr. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance:Guidelines for the prevention of antimicrobial resistance in hospitals[J].Clinical Infectious Diseases,1997,(03):584-599.
  • 2Blaser J,Stone BB,Groner MC. Comparative study with enoxacin and netilimicin in a pharmacodynamic model to determine importance of ratio and antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance[J].Antimicrobial Agents and Chemotherapy,1987,(07):1054-1060.
  • 3Gerding DN,Larson TA,Hughes RA. Aminoglycoside resistance and aminoglycoside usage:Ten years of experience in one hospital[J].Antimicrobial Agents and Chemotherapy,1991,(07):1284-1290.
  • 4Forrest A,Nix DE,Ballow CH. Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients[J].Antimicrobial Agents and Chemotherapy,1993,(05):1073-1081.
  • 5Javis WR. Preventing the emergence of multidrug-resistant microorganisms through antimicrobial use controls:The complexity of the problem[J].Infection Control and Hospital Epidemiology,1996,(08):490-495.
  • 6Hyatt JM,Scbentag JJ. Potential role of pharmacokinetics,pharmacodynamics,and computerized databases in controlling bacterial resistance[J].Infection Control and Hospital Epidemiology,2000,(1Suppl):S18-S21.

同被引文献9

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部